Good morning, and welcome to Ocugen's Webcast to discuss the Top Line 12-month Results from Phase II ArMaDa Clinical Trial Evaluating OCU410 for Geographic Atrophy or GA Secondary to Dry Age-related ...
Patients continuously monitored after surgery experienced significantly less time with dangerously low oxygen levels compared ...
Cornell scientists have engineered E. coli to act as a sensitive biosensor for monitoring environmental arsenic, a toxic ...
Following the End-of-Phase 2 meeting with the FDA, the Company gained alignment on its Phase 3 program for the treatment of patients with idiopathic pulmonary fibrosis-related chronic cough On track ...
Following the End-of-Phase 2 meeting with the FDA, the Company gained alignment on its Phase 3 program for the treatment of ...
Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the ...
Hansoh’s olatorepatide achieved 19% weight loss at 48 weeks in a Phase 3 trial in China, handing partner Regeneron a glimmer of hope for a pipeline in desperate need of reinvigoration. Regeneron’s ...
XRP plunges a large portion of its holders into the red. The latest on-chain reading shows that a considerable amount of tokens has now fallen below its purchase price, bringing unrealized losses to ...
FDA authorization under an IND permits first-in-human phase I/II testing of SVT-001 in familial drusen, focusing on safety with preliminary assessments of visual and retinal functional outcomes.
Genentech on Thursday shared topline results from the Phase 2 ZUPREME-1 trial evaluating petrelintide versus placebo in 493 obese participants (mean BMI of 37 kg/m²). In 2025, Genentech and Roche ...
SAR-powered monitoring delivers reliable insights through cloud cover, enabling near real-time response to illegal logging and mining The launch comes amid sustained pressure to protect the Amazon ...
(RTTNews) - Tectonic Therapeutics, Inc. (TECX), a clinical-stage biotechnology company, reported fourth-quarter and full-year 2025 results and provided an update on the progress of its clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results